Home
>
National Drug Code (NDC)
>
ERYTHROMYCIN
ERYTHROMYCIN - 16590-088-20 - (ERYTHROMYCIN)
Drug Information of ERYTHROMYCIN
| Product NDC: | 16590-088 |
| Proprietary Name: | ERYTHROMYCIN |
| Non Proprietary Name: | ERYTHROMYCIN |
| Active Ingredient(s): | 250 mg/1 & nbsp; ERYTHROMYCIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ERYTHROMYCIN
| Product NDC: | 16590-088 |
| Labeler Name: | Stat Rx USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062746 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19861222 |
Package Information of ERYTHROMYCIN
| Package NDC: | 16590-088-20 |
| Package Description: | 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-088-20) |
NDC Information of ERYTHROMYCIN
| NDC Code | 16590-088-20 |
| Proprietary Name | ERYTHROMYCIN |
| Package Description | 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-088-20) |
| Product NDC | 16590-088 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ERYTHROMYCIN |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19861222 |
| Marketing Category Name | ANDA |
| Labeler Name | Stat Rx USA |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
